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ABSTRACT 
 
 
Inflammation in the developing central nervous system (CNS) can contribute to 
numerous issues in the fully developed adult. Uncovering pathways responsible for the 
inflammation is valuable for future intervention strategies aimed at preventing or 
reducing inflammation. Receptor interacting protein kinase 3 (RIP3) has recently been 
identified as a critical signaling molecule in initiating programmed necrosis (also termed 
necroptosis), which may contribute to cell damage and subsequent inflammation under 
pathophysiological conditions such as stroke and traumatic injury.  The goal of this 
study was to use genetic approaches to determine the role of RIP3 in brain immune 
responses after systemic inflammatory challenge and the contribution of RIP3 to 
inflammation-induced potentiation of hippocampal injury in an ex vivo model of 
hypoxia/ischemia.   Stimulation with lipopolysaccharide (LPS) elicited robust 
proinflammatory responses of organotypic hippocampal slices and significantly 
exacerbated CA1 neuronal excitotoxicity after subsequent oxygen glucose deprivation 
(OGD).  Genetic ablation of RIP3 resulted in decreased levels of interleukin-1β (IL-1β) 
after LPS stimulation and suppressed excitotoxicity after subsequent OGD challenge. 
These results suggest that activation of RIP3 increases proinflammatory responses in 
cultured hippocampal slices.  To determine if RIP3 regulates inflammation in vivo, we 
examined cytokine and chemokine levels of the brain after subcutaneous LPS 
administration followed by hypoxia in early postnatal pups.  Mice lacking RIP3 
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produced significantly lower levels of proinflammatory cytokine IL-1β 6-24 hours after 
LPS administration when compared to wildtype RIP3+/+ littermates.  In contrast, 4 and 
21 days after LPS administration followed by hypoxia, IL-1β and other proinflammatory 
cytokine transcript levels in the brain were drastically diminished and were comparable 
between RIP3+/+ and RIP3-/- mice.  Our preliminary data suggest that these RIP3-/- mice 
show lower expression of genes responsible for myelination.  In summary, our results 
demonstrate, for the first time, that RIP3 mediates proinflammatory responses in the 
CNS by enhancing IL-1β production and imply that RIP3 is a potential target for 
neuroinflammatory disorders.  
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NOMENCLATURE 
 
 
ANOVA  analysis of variance 
Ara-C   cytosine b-D-arabinofuranoside 
CA1   region 1 of hippocampus proper 
CC1   APC immunogen clone CC1 
CCL2   chemokine ligand 2 
CCL3   chemokine ligand 3 
CCL5   chemokine ligand 5 
cDNA   complementary deoxyribonucleic acid 
CNP   2’,3’-Cyclic-nucleotide 3’-phosphodiesterase 
CNS   central nervous system 
CV   cresyl violet 
DMEM  dulbecco’s modified eagle medium 
DMFI   change in mean fluorescent intensity 
DNA   deoxyribonucleic acid 
EBSS   earl’s balanced salt solution  
EDTA   ethylenediaminetetraacetic acid 
FBS   fetal bovine serum 
GFAP   glial fibrillary acidic protein 
H + E   haematoxylin and eosin 
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IACUC  institutional animal care and use committee 
IHC   immunohistochemistry 
IL-18   interleukin 18 
IL-1b   interleukin 1 beta 
IL-6   interleukin 6 
LDL   low density lipoprotein 
LME   L-leucine methyl ester 
LPS   lipopolysaccharide 
MAG   myelin associated glycoprotein 
MAP2   microtubule-associated protein 2 
MBP   myelin basic protein 
MEM   minimal essential medium 
mRNA   messenger ribonucleic acid 
NB   neurobasal 
Nec-1   necrostatin 1 
NLRP   NACHT, LRR, and PYD domains-containing protein 
NMDA  N-methyl-D-aspartic acid 
ns   not significant 
OGD   oxygen glucose deprivation 
P/S   penicillin/streptomycin 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
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PDL   poly-D-lysine 
PFA   paraformaldehyde 
PI   propidium iodide 
PLP   proteolipid protein 
qPCR   quantitative polymerase chain reaction 
RHIM   receptor interacting homotypic interacting motif 
RIP1   receptor interacting protein 1 
RIP3    receptor interacting protein 3 
ROS   reactive oxygen species 
RT-qPCR  reverse transcription-quantitative polymerase chain reaction 
SDM   slice dissection medium 
SEM   standard error of the mean 
SFM   serum free medium 
TAMU  Texas A&M University 
TLR   toll-like receptor 
TNF-a   tumor necrosis factor alpha 
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CHAPTER I 
INTRODUCTION 
 
 
The CNS is solely dependent upon oxygen consumption, and consumption 
occurs at a very high rate. In this oxygenated environment, increased reactive oxygen 
species (ROS) production is counter balanced with various defense mechanisms that 
remove ROS and related metabolites.  Overproduction of ROS results in oxidative stress, 
which has been linked to many diseases (Finkel and Holbrook, 2000) and can cause  
programmed cell death (Vandenabeele et al., 2010a). In addition, prior work reveals an 
importance of inflammation along with oxidative stresses, which lead to injury (Sheldon 
et al., 2004, Barks et al., 2008). Our overall hypothesis is that reduced oxygen combined 
with inflammation carries heavy consequences to the development of the brain. 
Hypoxia and systemic inflammation in the developing brain 
  During one of many scenarios, inflammation can occur when cells undergo death 
by means of necrosis because they spew their contents into the extracellular 
environment. This can be reduced by antioxidants such as vitamin E and other members 
of this family (Ahn et al., 2007).  Clinical and experimental studies have shown that 
hypoxia/ischemia and maternal/fetal infection are risk factors for the developing brain 
(Rousset et al., 2006, Rousset et al., 2013). In neonates, a hypoxic and ischemic 
environment causes pathology that is visible starting 3 hours up to 100 days after insult 
with massive tissue injury and atrophy including activated glial cells. This could lead to 
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cerebral palsy and cognitive impairments that can also alter social skills, attention span, 
and overall behavioral alterations (Shrivastava et al., 2012). Systemic inflammation 
triggered by E. coli exacerbates hypoxic/ischemic brain injury and leads to myelination 
deficits (Loron et al., 2011) and damage to healthy cells in the developing brain, which 
is most likely due to aberrant innate immune responses in the brain. There exist many 
possible avenues for activating the innate immune system, and in all of these 
possibilities, the developing brain becomes increasingly susceptible to brain injury. For 
example, the developing brain becomes more susceptible to cerebral palsy, along with 
various abnormalities occurring in the white matter (Mallard and Wang, 2012). Others 
use LPS, a cell wall component of gram-negative bacteria to show that systemic 
inflammation can lead to long term neurological consequences such as motor 
dysfunction (Rousset et al., 2013), and white matter damage (Favrais et al., 2011). 
Activation of N-methyl-D-aspartate (NMDA) receptors on microglia are activated (by 
LPS for example), which results in release of proinflammatory cytokines and factors that 
cause neuronal cell death (Kaindl et al., 2012).  
Role for RIP3 in regulated necrosis and inflammation 
RIP3 is the third member of a family of receptor interacting proteins and is found 
on chromosome 14 (Kasof et al., 2000). This protein was named as a part of this family 
when initial experiments using a yeast two hybrid screen found it to bind to receptor 
interacting protein 1 (RIP1) (Yu et al., 1999). RIP3 was also found to be involved in 
activation of proinflammatory signaling pathways (Pazdernik et al., 1999, Sun et al., 
1999). RIP3, through its receptor interacting homotypic interacting motif (RHIM), 
  3 
interacts with RIP1 (Sun et al., 2002) (Figure 1) and the formation of RIP1/RIP3 
complex and RIP1 kinase activity have been shown to be critical in initiating 
programmed necrosis (Figure 2), which challenged the central dogma that apoptosis was 
the only means of programmed cell death and ignited prolific research interest in the 
field (Vandenabeele et al., 2010b, Ofengeim and Yuan, 2013). 
The small molecule named necrostatin-1 (Nec-1) that targets the kinase activity 
of RIP1 (Degterev et al., 2005, Degterev et al., 2008) has been shown to significantly 
decrease injury and infarct size in ischemic kidney (Linkermann et al., 2012), heart 
(Oerlemans et al., 2012), and brain (Northington et al., 2011). Administration of nec-1 
also significantly reduced cell death when given promptly after hypoxia/ischemia 
(Chavez-Valdez et al., 2012, Linkermann et al., 2012). These studies suggest that 
programmed necrosis may contribute to ischemic brain tissue damage.  
Later subsequent studies from three independent groups simultaneously 
identified RIP3 in acting as a “master switch” of tumor necrosis factor alpha (TNF-α)-
induced cell death from apoptosis to necrosis (Cho et al., 2009, He et al., 2009, Zhang et 
al., 2009). Given that Nec-1 is protective against ischemic brain damage and that RIP3 
interacts with RIP1 and is critical in triggering necroptosis, a genetic approach with 
RIP3-/- mice would bypass potential off-target effects of nec-1 in vivo (Vandenabeele et 
al., 2013) and provide valuable insights into the potential function of  RIP3 during 
ischemia and inflammation in the CNS.  
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Figure 1 The similarities and differences between receptor interacting proteins. Both 
proteins have a kinase domain (KD), and RIP homotypic interacting motif (RHIM) while 
RIP3 lacks a death domain (DD). 
 
 
Figure 2 Signaling pathways involving RIP3. The following cartoon depicts the 
simplified involvement of RIP3 in pathways leading to inflammation. 
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Experimental model systems used in our studies 
Maternal exposure to LPS during gestation causes hypomyelination, programmed 
cell death of all cells in specific areas of the fetus (Rousset et al., 2006), and activation 
of NMDA receptors on microglia (Kaindl et al., 2012). Since maternal exposure to LPS 
produces injury during postnatal development, we used a mouse line where RIP3 gene is 
ablated (He et al., 2009) to determine if RIP3 regulates brain immune responses 
followed by the outcome of systemic LPS exposure to newborn mouse pups. A well-
established experimental model (Nobuta et al., 2012) was adapted for this current study.  
Briefly, a certain regime of LPS administration at particular times induces white matter 
damage. In addition, we employed organotypic slice cultures, which maintain synaptic 
connections and preserve the relevant stoichiometry of the glia and neurons (Sundstrom 
et al., 2005), to establish an in vitro inflammation and oxygen glucose deprivation 
(OGD) model to partially mimic the in vivo systemic LPS injections in RIP3 null 
postnatal mice. The overall goal of this study is to investigate how the CNS immune 
response is regulated during early postnatal brain development and, to our knowledge, is 
the first to use a genetic RIP3 mutant mouse line to examine the immune responses in 
the developing CNS after systemic inflammation.  
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CHAPTER II 
 MATERIALS AND METHODS 
 
 
Materials  
Earl’s balanced salt solution (EBSS), hank’s balanced salt solution (HBSS), 
dulbecco’s modified eagle medium (DMEM) with high glucose, and fetal bovine serum 
(FBS) were purchased from Hyclone (Logan, UT). Neurobasal Medium (NB) and B27 
supplement were purchased from Gibco/Life Technologies (Carlsbad, CA). Antibodies 
against RIP1 and RIP3 were purchased from R&D Systems (Minneapolis, MN) and 
Imgenex (San Diego, CA) respectively. Hoechst 33342 for nuclei staining and Alexa 
488 and 594 was from Invitrogen (Carlsbad, CA). Rabbit monoclonal anti-microtubule-
associated protein 2 (MAP2) antibody was purchased from Cell Signaling Technology 
(Danvers, MA). Glial fibrillary acidic protein (GFAP) and APC immunogen clone CC1 
(CC1) were purchased from Calbiochem (Billerica, MA). Rat monoclonal anti-CD68 
antibody was purchased from AbD Serotec (Raliegh, NC). Rabbit polyclonal anti-Iba-1 
antibody was purchased from Wako Chemicals (Richmond, VA). Antibodies to nestin, 
TBR2, and Olig2 were purchased from Millipore (Billerica, MA). All other reagents 
used were purchased from Sigma-Aldrich (St. Louis, MO).  
Genotyping 
Mice used were generated as described by (He et al., 2009). Tissue for 
genotyping was obtained from the last centimeter of the animal’s tail. Tail clips were 
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then digested in tissue digestion buffer (50 mM Tris 20 mM NaCl 1 mM EDTA 1% SDS 
0.5 mg/ml Proteinase K) for 20 minutes at 550 C. Then 200 µL of water was added to 
each sample and boiled for 5 minutes. After 10 minutes at 14,000 rpm, the supernatant 
DNA was quantified using a Nanodrop 1000 photospectrometer, and 50 ng of DNA per 
reaction was used for PCR. PCR with RIP3 gene specific primers (Table 1) was carried 
out as follows: an initial denaturing step for 2 minutes at 940 C, followed by 35 cycles of 
three steps (940 C for 30 seconds, 600 C for 30 seconds, 720 C for 60 seconds) and a final 
elongation step at 720 C for 10 minutes. Samples were then run in a 1% agarose gel for 
30 minutes at 130 volts (constant) and then imaged using Chemidox XRS gel 
documentation system (Bio-rad Hercules, CA). One of three different outcomes for 
genotype was possible based on PCR product size as shown below (Figure 2). 
 
 
 
Table 1 Genotyping primer sequences. Targeted for mouse (Newton et al., 2004). 
Primer Name Sequence (5’ to 3’) 
RIP3 Fwd ACATGCATGGTCATGCACACACAT 
RIP3 Rev WT TTGAGACAGGGTCTCTTTTTGGAG 
RIP3 Rev KO GTCGAGGGACCTAATAACTTCGTA 
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Figure 3 PCR product size and distribution based on genotype. Agarose gel visual of 
PCR product size obtained based on animal genotype. 
 
Primary astrocytes 
Astrocytes were prepared using previously described methods (Li 2008).  Once 
meninges were removed under a stereo dissection microscope, the brain tissue was 
digested using HBSS with 0.01% Trypsin and 10µg/ml DNAse for 15 minutes at 370 C. 
Tissue was then re-suspended and washed twice with DMEM plus 10% FBS and 1% 
penicillin/streptomycin (P/S). Following the second wash, cells in suspension were 
passed through a 70 micron nylon cell strainer onto poly-D-lysine (PDL) coated 75 
cm2 flasks. Media [DMEM, 10% FBS, and 1% P/S] was changed every other day for a 
week. On the seventh day, microglia and pre-oligodendrocytes (pre-OLs) were removed 
from the culture by shaking at 200 rpm for 13-15 hours in a 370 C incubator. The same 
procedure was repeated a week later. To purify the astrocytes from any remaining 
microglia, a specific toxin to microglia called L-leucine methyl ester (LME) (1mM) was 
incubated with the monolayer for 1h at 370 C. Astrocytes were then split, re-plated to a 
lower density in DMEM 10% FBS 1% P/S, and allowed to proliferate for three days. 
After proliferation, the astrocytes were treated with LME again for one hour at 370 C, 
washed twice with PBS, centrifuged at 0.1 relative centrifugal force (rcf), re-suspended 
  9 
in D10S, and plated onto 96 well, 8 well chamber slides, or 24 well plates at 5.0 X 104 
cells /mL.  
Primary neurons 
Adult Sprague-Dawley rats or C57/B6 mice at E16 stage of pregnancy were 
euthanized according to a procedure approved by Texas A&M University institutional 
animal care and use committee (TAMU IACUC). Following euthanasia, an incision was 
made in the abdominal region to remove the embryo sacs. Once obtained, 
microdissection scissors were used to remove each embryo from the sac followed by 
removing the brain from the embryo. Brains were then placed into cold HBSS inside a 
10 cm petri dish on top of an ice pack. The meninges were removed with fine forceps 
under a stereo dissection microscope inside of a laminar flow hood. The brain was then 
separated into regions and only the cortical and hippocampal regions were used while 
the midbrain and hindbrain was discarded. These brain tissues were then digested for 5 
minutes inside a 370 C water bath using 5 mg of freshly prepared papain in HBSS. To 
stop the activity of papain, tissues were incubated with 10mg/ml trypsin inhibitor 3 times 
total, each with 3 minute incubation in the 370 C water bath.  DMEM containing 
glutamine and 10% FBS was then used to titrate out the suspension until it was 
homogenous with no clumps. This suspension was then passed through a 70 micron cell 
strainer into a 50 mL falcon tube. Cells were diluted to a final density of 2.5 
X105 cells/cm2 and plated into 96 well plates for experiments. The next day, the media 
was carefully removed, rinsed out with phosphate buffered saline (PBS), and replaced 
with NB medium plus B27 supplement containing 3mM Cytosine b-D-arabinofuranoside 
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(Ara-C). Treatment with Ara-C for 72 hours gave highly purified neuronal cultures and 
at day 3 in vitro (DIV3), the medium containing Ara-C was replaced with NB Medium 
plus B27 supplement. Every other day thereafter, half changes of the media were 
performed until the cells were ready for experiments. Immature neuronal cultures 
between DIV4 to DIV6 were used for all experiments. 
Immunocytochemistry and immunohistochemistry with fluorescence microscopy 
Before obtaining brain tissue, each mouse was transcardially perfused using PBS. 
However, if the mouse was aged less than postnatal day 7, no perfusion was carried out. 
Obtained brain tissues were then fixed in 4% paraformaldehyde (PFA) for 12-24 hours at 
40 C, cryoprotected with 30% sucrose in PBS, and cut into 10 micron sections and 
placed onto plus coated glass slides. Using PBS, tissue sections were rinsed 3 times total, 
allowing 5 minutes of incubation for each rinse. Next, cells were blocked and 
permeabilized using 5% goat serum and 0.3% Triton X in PBS for 1 hour at room 
temperature. Once blocking was complete, the slide was rinsed once with PBS. Next, the 
primary antibody was diluted to desired concentration in PBS with 0.1% Triton X.  The 
following antibodies were used: GFAP at 1:300, Iba-1 at 1:300, CC1 at 1:200, Nestin at 
1:100, TBR2 at 1:100, Olig 2 at 1:1000, and CD68 at 1:100. This was then added to the 
slide, and allowed to incubate overnight at 40 C. The next day, the slide was rinsed 3 
times for 5 minutes each using PBS. Then the respective secondary antibody conjugated 
to either Alexa 488 or 594 was used at a1:1000 dilution. This mixture was added to the 
slide and incubated for 1 hour at room temperature. Following secondary antibody 
incubation, the slide was washed 3 times for 5 minutes each using PBS. The final wash 
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used Hoechst 33342 added at a 1:10,000 dilution in order to label the nuclei. After 5 
minutes, this mixture was rinsed out and then PBS was added to the slide. Next, the 
cultures were  imaged for analysis and nuclei cell counting. 
Organotypic hippocampal slice cultures 
5 to 6 day old mice were anesthetized and decapitated followed by removal of 
the whole brain. The first 1-3 mm of each hemisphere was removed from the anterior 
portion and the entire cerebellum and brainstem from the posterior portion. Using a 
sterile razor blade, the brain was divided into the left and right hemisphere. The whole 
brain was super glued anterior side down onto the stage of the vibratome (Leica model 
VT1200) and immersed into ice-cold slice dissection medium (SDM) [EBSS with 25 
mM HEPES, 1.8 mM CaCl2, 0.813 mM MgSO4]. Starting from the posterior end, 400 
micron slices were cut with the vibratome set to 1.80 mm amplitude and 0.05 mm/sec. 
Slices were transferred to a 100 cm petri dish containing SDM, which was chilled using 
an ice pack placed on a stereo dissection microscope. Under the stereo dissection 
microscope, using a set of bent and dulled half inch 27 gauge needles attached to 1 mL 
syringes, the cortical region was detached from the hippocampus. All other structures 
besides the hippocampus were trimmed away so that only the hippocampus remained. 
Using a plastic transfer pipet, the hippocampi were transferred to 50 mL conical tubes 
containing SDM and placed on ice for 15-30 minutes. Next, slices were transferred onto 
Millicell membrane inserts in a 6 well plate placed in 1 mL of slice feeding medium 
(SFM) [50% minimum essential medium (MEM), 25% EBSS, 25% heat-inactivated 
horse serum, 2 mM GlutaMAX-I, 5 mg/ml D-Glucose, 100 U/ml P/S, and 1 µg/mL 
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Fungizone at pH 7.2]. These slices were grown for 9 days before experimental use. 
Every other day, half the media was removed and replaced with fresh media. 
Oxygen glucose deprivation (OGD) 
After 8 days in culture, slices were pre-treated with 1 µg/ml LPS and 1 µg/ml 
propidium iodide (PI). PI was incorporated into all the media for the entire experiment 
and is used to trace dying cells. 24 hours later, after three washes with PBS, 
hippocampal slices were subjected to OGD in glucose-free SFM where glucose was 
replaced with an equal concentration of sucrose.  This media lacking glucose was 
bubbled with 95% N2 and 5% CO2 gas for 30 minutes to remove the oxygen. The slices 
were washed three times with this media for 10 minutes each. The slices were then 
placed into a hypoxia chamber, which was sealed to be air tight and flushed with N2 gas 
to remove all oxygen. After ten minutes of N2/CO2 flushing (twenty 30 second cycles), 
the chamber was sealed and placed into the 370 C incubator for 45 minutes. Normoxia 
control slices were given the same media formulation with the addition of 25 mM 
glucose and normal oxygen environment. Following this incubation, the slices were 
given glucose containing SFM (without serum) and allowed to recover for 24 hours. 
Slices were then imaged for PI fluorescence under the microscope.  
Subcutaneous lipopolysaccharide (LPS) administration and hypoxia 
LPS was purchased from Sigma (E. coli strain 011:B4) and determined that 1 
mg/kg body weight was sufficient to consistently cause inflammation after 2 
subcutaneous injections between each shoulder. LPS was diluted in sterile PBS and 
administered subcutaneously in a volume of 20 µL. Pups at postnatal day 2 and weighing 
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between 1.5 to 1.8 grams were used for these administrations (Nobuta et al., 2012). If the 
animals fell below this weight limit, there was a 12-15 hour waiting period before the 
first administration was given. Between 15-17 hours after the first injection, the second 
injection was given on the opposite shoulder. There were two experimental groups: One 
group of animals was sacrificed 24 hours after the first injection. The second group 
examined the effects of 1 hour with hypoxia (92% N2 and 8% O2). The animals in the 
second group were subjected to hypoxia (8% O2, 1 hour) 8 hours after the second 
injection, and were then returned to the dam for an additional 48 hours, 10 days, or 21 
days. At the respective time points, the animals were sacrificed and their brain was used 
for further analysis. The brain was split into two hemispheres. One hemisphere was flash 
frozen in liquid nitrogen to be used for mRNA analysis while the other hemisphere was 
fixed in 4% PFA, cryoprotected in 30% sucrose, and sectioned for immunohistochemical 
analysis. 
RNA isolation and RT-qPCR 
RNA was extracted from brain hemisphere tissue using TRI Reagent® (Sigma, 
St. Louis, MO) according to manufacturer’s instructions. Quantified nucleic acids 
obtained from this procedure were then converted to cDNA as follows. The 
contaminating DNA was digested and removed using DNase I kit (Life Technologies 
Carlsbad, CA) followed by reverse transcription using AMV kit (Promega Madison, 
WI). To check for successful reverse transcription, PCR using 100 ng cDNA was 
performed to verify amplification. For qPCR, 10 ng of cDNA was used to amplify the 
following genes (Table 2). The SYBR dye was used according to manufacturer’s 
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instructions (Life Technologies, Grand Island, NY). All samples were run using a 
CFX384 Touch™ Real-Time PCR Detection System (Bio-Rad, Hercules, CA) in 
duplicate. Gene expression was normalized to β-actin expression. Fold expression was 
calculated using the formula 2-ΔΔCt (Livak and Schmittgen, 2001). 
 
 
 
Table 2 qPCR primers. Primers made using mouse genes. 
Gene Forward (5’ to 3’) Reverse (5’ to 3’) 
CNP AGGAGAAGCTTGAGCTGGTC CGATCTCTTCACCACCTCCT 
MAG GATGATATTCCTCGCCACC ACTGACCTCCACTTCCGTT 
MBP CACACACGAGAACTACCCA GGTGTTCGAGGTGTCACAA 
CCL2 GGCTCAGCCAGATGCAGTTA GCTGCTGGTGATCCTCTTGT 
CCL3 CCGGAAGATTCCACGCCAAT GTCTCTTTGGAGTCAGCGCA 
CCL5 GCCAGCTTGGGGATGCCACTC CAGAGCCTCGGAGCAGCTGAG 
TNFα TGTCCCTTTCACTCACTGGC CATCTTTTGGGGGAGTGCCT 
IL-1β CGACAAAATACCTGTGGCCT TTCTTTGGGTATTGCTTGGG 
IL-6 TGGTGACCACGGCCTTCC AGCCTCCGACTTGTGAAGTGGT 
β-
actin 
ATGTGGATCAGCAAGCAGGA AAAGGGTGTAAAACGCAGCTC 
IL-18 ACGTGTTCCAGGACACAACA ACAAACCCTCCCCACCTAAC 
IL-10 TGAGGATCAGCAGGGGCCAGT CTGGCTGAAGGCAGTCCGCA 
RIP3 GCCTTCCTCTCAGTCCACAC CTTTGCCCACAAACTCCAGC 
  15 
Image analysis- cell counts and fluorescence intensity analysis 
Fluorescent intensity of PI positive cells in the CA1 region of hippocampal slice 
cultures was used to determine neuronal cell death. In addition, sagittal sections of one 
hemisphere of the mouse brain were used to count Iba-1 and CC1 positive cells in the 
hippocampus region. Images were obtained using an Olympus IX71 microscope and 
Olympus DP70 digital camera at equal exposure. Using ImageJ, background was 
subtracted, and images were converted to binary followed by measuring the pixel 
intensity. The intensity value at 24 hours was subtracted from the intensity value at 0 
hours to determine the change in mean fluorescent intensity (ΔMFI). To determine Iba-
1+ and CC1+ cell numbers, the images with the respective marker were merged with a 
Hoechst 33342 image of the same spot. The merged images were used for analysis by 
first measuring the area of the hippocampus (as mm2) and counting the nucleated Iba-1+ 
and CC1+ cells in each field. The resulting data was expressed as cells/mm2. 
Use of laboratory animals 
All protocols for animal use were approved by the TAMU IACUC prior to the 
start of experiments. 
Statistics 
All graphs are shown as means + standard error (SEM). To determine if 
differences existed between groups we used one-way analysis of variance (ANOVA) 
followed by Bonferroni’s post-hoc test. All calculations to determine significance were 
made using GraphPad Prism 4 (GraphPad Software, San Diego, CA). If p<0.05, then we 
considered this a significant difference while p>0.05 was considered not significant (ns). 
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CHAPTER III 
 RESULTS 
 
 
RIP3 is predominantly expressed in microglia 
We obtained lysates from the purified primary cultures of respective cell type 
from neonatal rat brain: microglia, oligodendrocytes, neurons, and astrocytes. The 
lysates obtained from cultures were used for Western blot analysis. We determined that 
microglia are the cells that produce the highest level of RIP3 protein within the CNS 
(Figure 4A). The relative amount of RIP3 protein is also highest in microglia. We see 
that this is the case and in agreement with the visual of the western blot experiment We 
arrived at this conclusion when we compared RIP3 signal to uniform and unchanged 
levels of β-actin signal (Figure 4B). 
 
Figure 4 Microglia predominantly express RIP3. (A) Western Blot analysis of lysates 
from primary microglia (MG), oligodendrocytes (OL), mature neurons (N), and 
astrocytes (AST) using antibodies against RIP3 and b-actin. (B) Relative expression of 
RIP3 protein compared to loading control β-actin reveals microglia as predominant 
producer of RIP3.  
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RIP3 reduces excitotoxicity in a hippocampal slice culture model 
We used hippocampal organotypic brain slices from postnatal day 4.5 mice and 
subjected these tissues to an in vitro experimental OGD paradigm as shown in Figure 
5A. The slices were incubated with medium containing 1 µg/ml PI to trace dying cells 
over the course of experiment. In order to determine that the media formulation was safe 
for culturing, we used glucose-free OGD media supplemented with 25 mM glucose and 
found no difference in PI signal after 24 hours. In addition, LPS itself had minimum 
toxicity on the slice cultures (Figure 5B). This glucose-free OGD media was used during 
the duration of OGD. At all other times before and after OGD, we used serum free slice 
feeding glucose-containing media. To examine the effect of inflammation on OGD 
treatment, we first established a mild OGD toxicity paradigm to produce limited 
neurotoxicity. To determine a potentiation effect of innate immune responses by 
microglia, LPS pretreatment was performed. Slices were incubated with 1 µg/ml LPS for 
24 hours, washed twice with OGD media, and then subjected to 45 minutes of OGD. 
The neurotoxicity was significantly higher with LPS pretreatment as seen by significant 
increase in the number of PI positive cells (Fig. 5C, D), and this neurotoxicity was 
completely abolished by MK-801, indicating that OGD induces NMDA receptor 
dependent excitotoxicity (Figure 5C, 5D). The results suggest that neurotoxicity caused 
by OGD is mediated primarily through NMDA receptors, which cause neuronal cell 
death.  In addition, pretreatment of slices with LPS for 24 hours prior to OGD markedly 
potentiates the effect of neurotoxicity caused by OGD, and LPS per se does not 
contribute to the neurotoxicity. 
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Figure 5 OGD in slice cultures is potentiated by LPS and blocked by MK-801. (A) 
experimental timeline for slice cultures kept nine days in vitro prior to performing OGD. 
(B) OGD media supplemented with glucose causes no cell death to slice cultures 
incubated with this media for 45 minutes. (C) Slice cultures exposed to oxygen-limited 
environment with no glucose in the media undergo excitotoxic cell death in the CA1 
region without NMDA receptor antagonist MK-801 and are protected in the presence of 
MK-801. (D) Slices pretreated with LPS followed by OGD show potentiated cell death 
in the CA1 region without MK-801 but are protected when MK-801 is present. Images 
representative from nine animals with three slices per condition from each animal in 
three independent experiments. Scale bar, 200 microns. 
 
Genetic ablation of RIP3  ameliorates LPS potentiation of OGD induced excitotoxicity 
Hippocampal slices cultured for 9 days in vitro (DIV 9) from wildtype, 
heterozygous, and knockout mice were examined after 24 hours of pretreatment with 
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LPS and followed by administration of OGD. The slice cultures from wildtype animals, 
which have both alleles for RIP3 show the most severe injury of the three groups while 
the heterozygous show moderate injury and the knockout show a significantly lower 
extent of injury to the CA1 region (Figure 6A). These findings are shown when 
quantified using ΔMFI, and a significant difference is seen (Figure 6B). In addition, we 
collected supernatant from slice cultures 24 hours after OGD and saw increased 
production of the cytokine TNF-α after LPS pretreatment, and showed a lower trend in 
the knockout cultures (Figure 6C). The results obtained here suggest that in the absence 
of RIP3, LPS-induced potentiation of OGD neurotoxicity is ameliorated in the CA1 
region of the hippocampus. 
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Figure 6 RIP3 deletion protects hippocampal slice cultures after OGD. (A) potentiated 
excitotoxicity with LPS pretreatment in all groups compared to OGD alone and 
increasingly reduced excitotoxicity in CA1 region when RIP3 is genetically deleted (B) 
Change in mean fluorescent intensity measurements of the CA1 regions in at least 3 
animals per genotype immediately after OGD until 24 hours after OGD (C) Cytokine 
TNF-α levels of slice cultures 24 hours after OGD show a significant increase in the 
wildtype with LPS pretreatment as expected while lack of RIP3 shows only a slight 
increase. Results are combined means + SE *P<0.05, **P<0.01, ***P<0.001. Each 
group represents 3 slices from three mice and three independent experiments. Scale bar, 
200 microns. 
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Systemic LPS administration increases CNS cytokine production within 24 hours in part 
through a RIP3-mediated pathway 
RIP3 wildtype and knockout mouse pups at postnatal day 2 were weighed, and 
pups weighing between 1.4-2.0 grams were given two 20 ml 1 mg/kg subcutaneous LPS 
injections in the shoulder region. The first injection was given at P2 and 17 hours later, 
the second injection was given on the opposite side. The total amount of LPS received 
by each pup was about 3.3 µg. The pups were then returned to the dam for an additional 
6 hours. 24 hours after the first injection, the animals were sacrificed and their brain was 
dissected out for use in frozen sectioning and RNA isolation. The experimental timeline 
is shown below (Figure 7A).  
Each animal was anesthetized then the brain was dissected and one hemisphere 
was fixed and cryoprotected while the other was flash frozen in liquid nitrogen. RNA 
extracted from the flash frozen hemisphere was used to determine changes in cytokines 
and chemokine transcripts using qPCR. Examination of seven proinflammatory 
cytokines and chemokines revealed changes in expression in the brain after systemic 
LPS administration. LPS administration causes a significant increase in TNF-α in 
wildtype but much less degree in knockout and there is an increase in wildtype 
compared to knockout (Figure 7B). In addition, LPS causes a significant increase in IL-
1β in wildtype but not knockout and there is a significant increase in wildtype compared 
to knockout (Figure 7C). IL-6 is significantly increased in knockout animals 
administered LPS, but not in wildtype (Figure 7G). Systemic LPS administration causes 
a significant increase in production of CCL2 for both wildtype and knockout with no 
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significant change between genotypes (Figure 7D). Production of CCL3 and CCL5 is 
significantly increased with LPS administration in both wildtype and knockout (Figure 
7E, 7H), and LPS administration causes no change in the production of IL-18 (Figure 
7F). Preliminary results also revealed significant up-regulation of RIP3 after systemic 
LPS administration in the wildtype mice (Figure 7I). These data demonstrate that 
systemic LPS administration causes significant increases of proinflammatory cytokine 
production in the developing brain and that ablation of RIP3 decreases brain production 
of TNF-α, IL-1β, CCL3 and CCL5.  In summary, these data suggest that peripheral LPS 
sub cutaneous administration sufficiently induces central production of cytokines 
involved in inflammation and removal of RIP3 is sufficient to lower levels of cytokine 
production after LPS administration. 
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Figure 7 Changes in proinflammatory cytokine transcript 24 hours after LPS 
administration. (A) Timeline for two injections of LPS followed by tissue collection. (B) 
Significant increase in TNF-α transcript in wildtype animals 24 hours after LPS 
administration with a significant reduction in the RIP3-/- animals. (C) IL-1β transcript is 
significantly increased after LPS but is significantly reduced in RIP3 knockout. The 
chemokines CCL2 (D), CCL3 (E), and CCL5 (H) are similarly significantly increased 
after LPS administration in wildtype but not knockout mice. (F) IL-18 transcript remains 
unaltered after LPS administration. When injected with LPS, wildtype but not knockout 
animals increase RIP3 transcript. Finally, with IL-6 the opposite trend of significant 
increase of transcript in knockout but not wildtype is seen (G). Results are combined 
means + SE *P<0.05, **P<0.01, ***P<0.001, ns not significant. Each group represents 
three mice from 6 independent experiments. 
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Immunohistochemistry (IHC) analysis reveals activated glia after systemic LPS 
administration 
In parallel to findings at the transcript level, we next examined the brain using 
IHC and markers for astrocytes (GFAP) and microglia (Iba-1).  Relative counts of Iba-1+ 
cells in the hippocampus revealed a significant increase in microglial activation after 
peripheral LPS administration. There is no significant difference in relative microglia 
number between genotypes (Figure 8A). Immunofluorescent images of the hippocampus 
region of naïve, wildtype, or knockout mice reveal lower numbers of microglia in naïve 
animals, but similar numbers between LPS administered wildtype and knockout animals 
(Figure 8B). Images of GFAP staining reveals increased expression of GFAP after LPS 
administration compared to naïve animals (Figure 8C). These results suggest that after 
LPS administration, expression of proinflammatory cytokines dramatically increases, 
microglia and astrocytes become activated, and proinflammatory cytokines are produced 
within 24 hours after LPS administration.  
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Figure 8 Histology in the CNS of animals 24 hours after LPS administration. Cells 
positive for Iba-1 are microglia while cells positive for GFAP are astrocytes. (A) Iba-1 
positive cells show a significant increase in microglia in both groups administered LPS 
with no significant difference between wildtype and knockout animals. Representative 
images from each group showing microglial cells (B) or astrocytes (C). Results are 
combined means + SE  **P<0.01, ns not significant. Each group represents three mice 
from 6 independent experiments. Asterisk represents magnified region, shown below. 
Scale bar, 200 microns. 
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 Brain inflammation after systemic LPS administration is largely subsided by 72 hours  
We next examined the effect of hypoxia in combination of peripheral 
inflammation as it can lead to cerebral palsy, learning difficulties, and overall behavioral 
modifications. Here we asked if combination of LPS/hypoxia caused persistent gliosis 
and subsequent hypomyelination. We made modifications to our previous two-dose LPS 
administration experiment. Two days after hypoxia, the pups were taken from the dam 
and placed into a chamber that produced an 8% oxygen environment for 1 hour. The 
experimental timeline below details the entire process (Figure 9A).  Next, we used half 
of the brain to extract RNA and examine cytokines and chemokines. We found almost 
no difference in cytokine transcript levels between wildtype and knockout animals after 
LPS administration. The following relative cytokine transcript levels of LPS 
administered animals show no difference between genotype: TNF-α, IL-18, IL-6, and 
CCL3 (Figure 9B, 9F, 9G, 9E). On the other hand, there appeared to be a noticeable 
difference when LPS was administered to the knockout animals compared to the 
wildtype for IL-1β, CCL2, and CCL5. Each of these appeared to be drastically reduced 
in knockout mice (Figure 9C, 9D, 9H). There were insufficient mouse numbers for all 
groups therefore significance was not established. These results suggest that 
inflammation and the resulting changes in cytokine and chemokine levels become 
resolved by 72 hours after the administration of LPS. 
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Figure 9 Cytokine levels after LPS administration plus hypoxia. (A) Timeline of 
experimental protocol. Preliminary pilot studies of animals injected with LPS followed 
by hypoxia and tissue collection 48 hours later show reduced increases in transcript. 
TNF-α (B), IL-1β (C), IL-18 (D) show higher increase in wildtype with lower increase in 
knockout while the chemokines CCL2 (F), CCL3 (G), CCL5 (H) show smaller to almost 
no increase compared to naïve and among LPS administered groups. The reversed trend 
seen in 24 hour injected animals is no longer different for IL-6 (E). No significance can 
be established, results representative of two independent experiments with two animals 
per group. 
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Comparable microgliosis between wildtype and RIP3 knockout mice 72 hours after LPS 
and hypoxia challenge 
We again used IHC to determine the number of Iba-1 positive microglia cells. 
Nuclei that also have Iba-1 staining are considered to be microglia. An increase was seen 
in the relative number of microglial cells in the hippocampus in LPS-treated animals as 
compared to naïve mice. However, there was no difference between genotypes (Figure 
10A). Representative immunofluorescence images for each group appear to have similar 
numbers of Iba-1 positive microglia in the hippocampus. Representative 10 x images are 
shown with an asterisk used to represent the zoomed in region shown magnified below 
(Figure 10B). These results suggest that subcutaneous LPS administration followed by 1 
hour of hypoxia increased proliferation and/or activation of microglia in the 
hippocampus of the pup at postnatal day 6 to a similar extent in both genotypes.    
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Figure 10 Histology in the CNS of animals administered LPS 2 days after hypoxia. (A) 
Iba-1 positive cells show an increase in microglia in both LPS administered groups with 
no difference between wildtype and knockout animals in a preliminary pilot run. 
Representative visual from each group showing microglia (B). No significance can be 
established, results representative of two independent experiments with two animals per 
group. Asterisk represents magnified region, shown below. Scale bar, 200 microns. 
 
Long-term consequences of early postnatal systemic LPS challenge  and transient 
hypoxia on the myelination program 
CNS myelination occurs most robustly during postnatal week 2 and 3 in rodents, 
and we next asked if early inflammation and hypoxia affected CNS myelination by 
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examining three relevant genes. The experimental timeline is shown below (Figure 
11A). After two doses of LPS followed by hypoxia, the pups were returned to the dam 
until weaning age at 21 days when they were sacrificed. There was no increase in 
proinflammatory cytokine levels at postnatal day 21 in treated mice when compared to 
non-treated naïve littermates (Figure 11B-H). Preliminary studies revealed that three of 
the genes responsible for myelination during normal CNS development appeared to be 
differentially expressed between treated wildtype and knockout animals. We observed an 
increase in 2’,3’-Cyclic-nucleotide 3’-phosphodiesterase (CNP) transcript in the LPS 
administered knockout mice compared to naïve mice (Figure 12A). In addition, there 
was an increase in myelin basic protein (MBP) transcript levels in knockout animals 
administered LPS compared to naïve mice (Figure 12B). On the other hand, we noticed a 
reduction in myelin associated glycoprotein (MAG) transcript levels after LPS injection 
in the knockout mice (Figure 12C).  Due to low number of mice in this experiment, 
further investigation is needed. 
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Figure 11 Proinflammatory cytokine and chemokine transcripts in P21 mice after LPS 
administration at P2-P3. (A) Experimental timeline. (B-E) cytokine levels are similar to 
naïve in all cytokines tested. No significance can be established, results representative of 
two independent experiments with two animals for naïve and wildtype and one animal 
for knockout. 
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Figure 12 Changes in transcript levels of myelination related genes at P21. (A) 
Experimental timeline. Pilot study of animals injected with LPS spent 3 weeks 
developing. Transcript levels in genes responsible for myelination including CNP (B), 
MBP (C), and MAG (D) showed no major change among groups. No significance can be 
established, results representative of two independent experiments with two animals for 
naïve and wildtype and one animal for knockout. 
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Reduced number of CC1+ oligodendrocytes in LPS injected wildtype mice 
compared to RIP3 knockout mice 
CC1 labels post-mitotic maturing OLs and was used to analyze the effect of LPS 
plus hypoxia on CNS myelination.  CC1 is a nuclear stain so that positive cells appear 
purple due to overlap of Hoechst 33342 in blue and CC1 in red. Littermate mice were 
challenged with LPS and hypoxia at P2-P4 as described earlier, and allowed to grow 
until weaning age, P21. Preliminary examination of the three groups (naïve, 
LPS/hypoxia wildtype (WT) and LPS/hypoxia knockout (KO)) revealed a reduction in 
the CC1+ cell numbers for wildtype compared to naïve mice, but treated knockout mice 
had nearly the same number of CC1+ cells per square millimeter as untreated naïve mice 
(Figure 13A). IHC and fluorescent images reveal the CC1+ cell population in the 
hippocampus at P21 (Figure 13B). These results suggest that LPS administration early 
during development may result in fewer CC1+ OLs when RIP3 is present. 
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Figure 13 Histology in the CNS of LPS injected animals at P21. CC1 is an 
oligodendrocyte specific marker. (A) CC1+ cells were counted from sagittal sections of 
the hippocampus region and little change was seen in both LPS administered groups (B) 
Representative visual from each group showing CC1+ cells. No significance can be 
established, results representative of two independent experiments with two animals per 
group. Asterisk represents magnified region, shown below. Scale bar, 200 microns. 
 
Changes in myelination in the hippocampus of P21 mice 
In a pilot study, we used myelin proteolipid protein (PLP) immunohistochemistry 
to evaluate potential effects of early postnatal LPS challenge on myelination. There 
appears to be moderate differences between Naïve (Figure 14A), wildtype (Figure 14B), 
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and knockout mice (Figure 14C). However, due to limited number of mice used in these 
experiments, further study with additional numbers of mice for each group are needed. 
 
Figure 14 Myelination program slightly altered by Hypoxia and LPS. Three weeks after 
a combination of LPS and hypoxia, sagittal sections were sectioned and stained with 
PLP in Naïve (A), LPS/hypoxia treated wildtype (B) and LPS/hypoxia treated knockout 
(C) animals. Results representative of two experiments with one mouse per group. 
Asterisk denotes differences in myelination.  Scale bar, 500 microns. 
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Organization of neurons in the hippocampus after LPS administration 
We stained sagittal frozen sections of the hippocampus with cresyl violet (CV) 
and Hematoxylin and Eosin (H+E), which reveal nuclear bodies and the nissil substance 
found within nuclei respectively.  Sections stained with H+E at 24 hours after LPS 
administration revealed expected hippocampal size and no dramatic reduction of neurons 
(Figure 15A). Two days after hypoxia and LPS injection, CV staining appears to show 
that some neurons are missing in CA1 region (Figure 15B). During the late time point 
(P21), the H+E staining shows a larger more developed hippocampus that appears 
unaltered (Figure 15C). These findings suggest that our experimental model of  
subcutaneous LPS administration and 1 hour of hypoxia does not cause overt 
disturbance in the overall neuronal structure and morphology of the hippocampus. 
Instead activation of glia and subsequent inflammation may lead to the consequences we 
have observed in these studies. 
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Figure 15 Neuron staining in the hippocampus. Frozen sagittal sections were stained 
using the H + E or CV methods. The hippocampus was still developing 24 hours after 
LPS injection at postnatal day 3 (A) with similar neuronal number and distribution. At 
postnatal day 5 (B), the hippocampus was further developed and larger with no major 
differences in neurons. Three weeks after injection at postnatal day 21 (C), the 
hippocampus was fully developed and larger with no change in neuron number. 
Representative images of three independent experiments with three mice per group.  
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CHAPTER IV 
 CONCLUSIONS 
 
 
Central to maintaining a balance between cell death, inflammation, and 
programmed apoptotic cell death lie two key proteins. Historically, apoptosis has been 
the well-known form while the idea that programmed cell death could cause 
inflammation was not. Caspase 8 is a key protein for death receptor-mediated apoptosis 
and our recent work shows that RIP3 is involved with necroptosis in TLR-activated 
microglia in culture (Kim and Li, 2013), which could potentially lead to inflammation. 
Many studies have come to important conclusions involving both of these proteins. For 
example, structures termed inflammasomes are activated during infection and promote 
maturation of proinflammatory cytokine IL-1β.  When caspase 8 is deleted, NLRP3 can 
assemble, a process that depends on RIP kinases (RIP1 & RIP3) (Kang et al., 2013). 
Other important findings include: inhibition of necroptosis by processing of CYLD-a 
substrate for proteolytic cleavage of caspase 8 (O'Donnell et al., 2011), inhibition of the 
synergistic complexes caspase-8-FLIP (L) which inhibits necrosis dependent on RIP3 
(Oberst et al., 2011), and mediation of RIP3 and caspase 8’s individual embryonic 
lethality (Kaiser et al., 2011). Finally, these two proteins have important roles in the 
immune system as noted during viral infection (Upton et al., 2010), and in T cell 
necroptotic mechanisms (Ch'en et al., 2011).  Therefore caspase 8 and RIP3 are 
important factors to consider when events of inflammation events occur. 
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Very little is known about whether RIP3 regulates brain immunity. In this study, 
we present data demonstrating that within the first 24 hours after systemic administration 
of LPS, the CNS immune system is activated and RIP3 is up-regulated in the brain and 
contributes to the extent of inflammation. Future work examining removal of Caspase 8 
and RIP3 in the CNS is vital for complete understanding of the findings obtained here. 
This family of receptor interacting proteins has been shown to involve themselves in 
mitochondrial integrity and oxidative stress (Rathinam et al., 2012, Wang et al., 2012). 
In the context of the nervous system, RIP3 has been shown to be involved in RIP-kinase 
mediated necrosis in photoreceptor cells (Trichonas et al., 2010) and is involved in rod 
and cone cell death which is triggered by kinase activity of RIP1/3 (Murakami et al., 
2012). These exciting finding shed light on neuroinflammation and cell death 
mechanisms in the CNS. Besides the CNS, the function of RIP3 is implicated throughout 
the body. For example, macrophages circulating throughout the body responding to 
oxidized low density lipoprotein (LDL) have been shown to undergo necrosis mediated 
by RIP3 and this explosion of macrophages was shown to play a role in atherosclerosis 
development (Lin et al., 2013).  
We demonstrated that neuron excitotoxicity in an ex vivo model of organotypic 
hippocampal slice culture can be reduced by removal of RIP3. Other studies examining 
RIP3 in other types of cells are newly emerging. For example, in the liver, many studies 
have implicated RIP3 in liver disease caused by acetaminophen toxicity (Luedde et al., 
2014). RIP3 has also been implicated in lung injury (Zhao et al., 2014), and  aortic 
abdominal aneurysm in necrosis of smooth muscle cells (Wang et al., 2015). The use of 
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genetic alteration by ablation, as used in this study, is one important approach to uncover 
important roles for RIP3. This is especially important due to a lack of inhibitors that are 
specific to RIP3. Necrostatin-1 is a compound that inhibits RIP1 activity and has been 
instrumental for our understanding of the role this family of proteins plays in the cell. It 
is important to note that Necrostatin-1 has been found to be involved in inhibiting 
activity of indoleamine-2,3-dioxygenase (IDO),  an enzyme that catalyzes formation of 
tryptophan to kynurenine. As a result, two separate names were given to the same 
chemical compound (Vandenabeele et al., 2013). Our previous work reveals a role for 
Necrostatin-1 in preventing oxidative stress in oligodendrocytes (Kim et al., 2010). This 
compound is heavily used in the field and as an example, recent work has used it to 
show that receptor interacting proteins are involved in intracerebral hemorrhage induced 
brain injury (Su et al., 2015).  
Preliminary studies outlined here show potential to help uncover new findings. 
For example, we show that early systemic inflammatory events may impact CNS 
myelination while others have shown that necrosis dependent on receptor interacting 
proteins drives lethal systemic inflammatory response syndrome (Duprez et al., 2011). 
Besides this broad array of findings, RIP3 has been implicated in weight loss regain in 
obese subjects (Goyenechea et al., 2009). Our study used two important approaches, an 
ex vivo slice culture model and an in vivo LPS hypoxia model to uncover the role RIP3 
plays in regulating innate immunity and inflammation. Our findings in the ex vivo model 
show that slices lacking RIP3 after LPS preconditioned OGD have reduced neuronal 
excitotoxicity. It is likely that RIP3-dependent IL-1β production underlies LPS-induced 
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potentiation of OGD excitotoxicity. Our findings with the in vivo models show that 
inflammation in the CNS occurs within the first 24 hours after peripheral challenge and 
gradually diminishes to normal levels over time, which may affect the normal 
development of the brain. 
In summary, our study was the first to use a genetic approach to investigate the 
role of RIP3 in inflammation and injury in the developing CNS. The microglia are the 
CNS resident cells that predominantly express RIP3. We found that ablation of RIP3 in 
our ex vivo model reduced CA1 excitotoxicity in OGD in slice cultures pre-treated with 
LPS. We also used an in vivo model system to administer LPS to early postnatal mice. 
This model revealed a role for RIP3 in producing increased levels of IL-1β immediately 
after LPS administration. From 72 hours after the LPS administration up until 21 days 
after, cytokine levels decreased over time to normal while other potential consequences 
remain to be examined. 
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